domingo, 11 de noviembre de 2018

Food and Drug Administration's regulatory shift on direct-to-consumer genetic tests for cancer risk. - PubMed - NCBI

Food and Drug Administration's regulatory shift on direct-to-consumer genetic tests for cancer risk. - PubMed - NCBI



 2018 Nov 2. doi: 10.1002/cncr.31773. [Epub ahead of print]

Food and Drug Administration's regulatory shift on direct-to-consumer genetic tests for cancer risk.


PMID:
 
30387874
 
DOI:
 
10.1002/cncr.31773

No hay comentarios: